Expedeon

Expedeon

Expert in cutting-edge innovative reagents and services for life sciences and diagnostics.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR20172018
Revenues5.0m<1m
% growth-(86 %)
EBITDA1.0m(<1m)
% EBITDA margin20 %(11 %)
Profit5.0m<1m
% profit margin100 %86 %
  • Edit
DateInvestorsAmountRound

£240k

Early VC

$6.5m

Debt
*

€120m

Acquisition
Total Funding$317k

Recent News about Expedeon

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Expedeon

Edit
Protein Discovery
ACQUISITION by Expedeon Nov 2011